Search

everythinglearnresearchcommunity

for

Search:↓

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

More research is needed to understand sex and racial differences in long COVID.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Hair loss is caused by genetics and hormones, diagnosed through examination and biopsy, and treated with medications or surgery.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Estrogens and progesterone are key in regulating melasma pigmentation.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Testosterone helps prevent skin damage in males by acting through both estrogen and androgen pathways.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.